- 40-80 10 30 . 20 + 6,25 , 25 30-60 . .
:
- 20-40 ;
240 .
3. :
- ij 10-20 , 2,5 ;
- 40-80 .
4. , ' :
- ( 0,1 , 20-40 , 10 ).
5. ó , :
- ͳ ( ) 0,4-0,5 10 100 0,9% , 25 /. ;
- 40-80 ;
- .
6. ó , :
, 5-10% .. . ( 7-10 . ) 1000-2500 ( , '). 5-20 (), (, ) () 30-40 .
7. ó , :
- ͳ ( ) 0,4-0,5 10 (. 5);
- ' - . "";
- - 20-40 .
8. - (, ).
9. .
3.1.2.4.
䳿 ()
:
1. , . .
2. ϳ , , , , , .
3. () , , ﳿ, , , .
|
|
|
4. ' , ( ) , , .
IV.
1.
1.1. () .
1.2. ³ , ( 30 ) 12 .
1.3. ³ , (2 ; 12 ) .
V. ˲
1. .. - // . 2008. 2 (2). . 13-18.
2. .., .., .., .. 糿 // . 2010. 6(14). . 51-67.
3. .. 糿 , . ? // . 2011. 3(17). . 29-36.
4. .., ѳ .., ... 糿 // . 2010. 1. . 3-12.
5. 28.10.2002 . 385 ', , ', ̳ 892/7180 12.11.2002 .
6. 05.10.2011 . 646 ³, , ⳻, ̳ 1414/20152 07.12.2011 .
7. 03.07.2006 . 436 "".
8. 01.06.2009 . 370 , ̳ 863\16879 14.09.2009.
9. 23.02.2000 33 .
10. 14.02.2012 110 , ' , ̳ 661/20974 28.05.2012 .
11. 17.11.2010 . 999 , ̳ 147/18885 03.02.2011 .
|
|
|
12. 23.02.2012 132 - ', (-) .
13. 29.03.2013 251 ' .
14. 28.09.2012 751 - ̳ .
15. 㳿 糿. ó // , 2011, 3, . 64-95.
16. . 糿 : // . 2010. 1. . 13-15.
17. ѳ .. 糿 (19992007 ) // . 2008. 2 (2). . 83-88.
18. ADVANCE Collaboration, Lancet 2007; 370:829-840.
19. Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29:636.
20. Costanzo S, Di Castelnuovo A, Donati MB, et al. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J AmCollCardiol 2010; 55:1339.
21. ESC Guidelines on the management of cardiovascular diseases during pregnancy, 2011.
22. J. A. Garcia-Donaire et al. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients. Blood Pressure, 2011; 20: 322334.
23. National Clinical Guideline Center. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. National Institute for Health and Clinical Excellence, NICE clinical guideline 107, 2010.
24. National Clinical Guideline Center. Hypertension. The clinical management of primary hypertension in adults. National Institute for Health and Clinical Excellence. Clinical guideline 127: Methods, evidence, and recommendations, 2011.
25. Noordzij M, Uiterwaal CS, Arends LR, et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005; 23:921).
26. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertension 2009; 27.
27. Resistant Hypertension: Diagnosis, Evaluation, and Treatment. A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research // Hypertension. 2008;51:1403-1419.
28. S.Bangalore et al. Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose. Circulation, 2011;123:2799-2810.
29. Sowerby Centre for Health Informatics at Newcastle. Hypertension in people who do not have diabetes mellitus, 2010.
30. The ACCORD Study Group, N Engl J Med, 2010, 362:1575-1585.
31. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. US department of Health and Human Service. NIH publication No 04-5230. August 2004.
1
ó
. - :
- ( );
- ( );
䳿;
;
쳿
糿, , :
|
|
|
;
( );
- , ;
- , ;
- .
糿, , 20 - 30 . , , ().
糿 ( 1-2 .) .
.
糿, , , .
+ 6,25 .
.
, , 45, α - . b- a-.
:
1. ﳿ .
2. i .
3. 䳿 , ( ) .
4. , .
2
ó
ó
